SMOC2, OGN, FCN3, and SERPINA3 could be biomarkers for the evaluation of acute decompensated heart failure caused by venous congestion
2024

Identifying Biomarkers for Heart Failure Related to Venous Congestion

Sample size: 95 publication 10 minutes Evidence: moderate

Author Information

Author(s): Yu Yiding, Yuan Huajing, Han Quancheng, Shi Jingle, Liu Xiujuan, Xue Yitao, Li Yan

Primary Institution: Shandong University of Traditional Chinese Medicine

Hypothesis

Can specific genes serve as biomarkers for evaluating acute decompensated heart failure caused by venous congestion?

Conclusion

The study identifies four key genes that could serve as biomarkers for assessing heart failure related to venous congestion.

Supporting Evidence

  • Four diagnostic genes for heart failure's pre-decompensation phase were identified: SMOC2, OGN, FCN3, and SERPINA3.
  • These genes showed high diagnostic potential, with AUCs for each gene exceeding 0.9.
  • The genomic AUC reached 0.942, indicating significant diagnostic potential.

Takeaway

Doctors can use certain genes to check if heart failure patients are getting worse because of fluid buildup in their bodies.

Methodology

The study used bioinformatics and machine learning to analyze gene expression data and identify diagnostic genes.

Potential Biases

Potential selection bias due to the use of a dataset from healthy individuals rather than actual heart failure patients.

Limitations

The study's findings may not fully apply to actual heart failure patients since the venous congestion model was based on healthy individuals.

Participant Demographics

The study involved 95 patients diagnosed with ischemic heart failure and 136 healthy controls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fcvm.2024.1406662

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication